GeoWealth Management LLC boosted its position in shares of The Cigna Group (NYSE:CI - Free Report) by 47.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,445 shares of the health services provider's stock after buying an additional 792 shares during the quarter. GeoWealth Management LLC's holdings in The Cigna Group were worth $675,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. TCTC Holdings LLC purchased a new position in The Cigna Group during the 4th quarter valued at about $25,000. Collier Financial purchased a new position in shares of The Cigna Group during the fourth quarter worth $32,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group during the fourth quarter worth $34,000. Compagnie Lombard Odier SCmA purchased a new stake in The Cigna Group in the 4th quarter worth $37,000. Finally, Heck Capital Advisors LLC acquired a new position in The Cigna Group in the 4th quarter valued at $53,000. 86.99% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on the stock. Wells Fargo & Company reduced their target price on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research note on Tuesday, February 4th. UBS Group cut their target price on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. Truist Financial upped their target price on shares of The Cigna Group from $375.00 to $385.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Robert W. Baird lowered their price objective on The Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Finally, Cantor Fitzgerald upped their price objective on shares of The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research note on Thursday, March 20th. Two investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $373.56.
Read Our Latest Analysis on CI
The Cigna Group Stock Performance
Shares of CI stock traded down $0.10 during trading hours on Friday, reaching $335.60. The stock had a trading volume of 1,400,117 shares, compared to its average volume of 1,700,174. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The firm has a 50-day simple moving average of $319.82 and a 200-day simple moving average of $310.69. The firm has a market capitalization of $91.85 billion, a PE ratio of 27.42, a price-to-earnings-growth ratio of 0.98 and a beta of 0.51. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.
The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the prior year, the business earned $6.79 EPS. As a group, equities analysts forecast that The Cigna Group will post 29.77 earnings per share for the current year.
The Cigna Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be issued a $1.51 dividend. The ex-dividend date is Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.80%. The Cigna Group's dividend payout ratio is 49.35%.
Insider Buying and Selling
In other news, insider Noelle K. Eder sold 9,944 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the transaction, the insider now directly owns 13,406 shares in the company, valued at $4,289,920. The trade was a 42.59 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO David Cordani sold 26,527 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the transaction, the chief executive officer now directly owns 127,767 shares in the company, valued at approximately $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 43,751 shares of company stock worth $13,603,991. 0.70% of the stock is owned by company insiders.
The Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading

Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.